Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
33
天
Limitations in PAR1-Targeted Screening of Antithrombotic Phytochemicals
作者
Arienmughare Oghenetega; Nimrah Bhatti; Hira Khalid; Emmanuel Edigberhi; Osamagbe Osaghae; Khurrum Shabbir展开收起
作者单位
1. Department of Medicine, University of Benin, Benin City, Nigeria; 2. Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan; 3. Department of Molecular Biology and Genetics, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan; 4. Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan展开收起
23
天
From Hypothesis-generating to Decision-grade: Making Finerenone–spironolactone Comparisons in HFpEF Globally Implementable
作者
M. Vijayasimha; M. Srikanth; Gurjeet Singh展开收起
作者单位
1. University Institute of Allied Health Science, Chandigarh University, Gharuan, Mohali, India; 2. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India展开收起
91
天
Lipoprotein (a) and Coronary Atherosclerosis in Intracoronary Imaging - YELLOW II – Lp(a) Study
作者
Chen Gurevitz; Yuliya Vengrenyuk; Shingo Minatoguchi; Keisuke Yasumura; Amit Hooda; Prakash Krishnan; Pedro Moreno; Jagat Narula; Samin Sharma; Robert S. Rosenson; Annapoorna S. Kini展开收起
作者单位
1. Metabolism and Lipids Program, The Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, USA; 2. The Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, USA; 3. UTHealth Sciences Center, Houston, USA; 4. Mount Sinai Hospital, New York, USA展开收起
93
天
Dapagliflozin Inhibits Thrombin Induced ADAM17 Phosphorylation and Downstream ERK/p-c-Jun-mediated CTGF Induction to Prevent Neointimal Hyperplasia
作者
Ting-Lin Yen; Po-Ching Chou; Chia-Ti Tsai; Yi-Ling Chen; Chieh-Yu Chen; Yi-Fan Chien; Wen-Chin Ko展开收起
作者单位
1. Department of Medical Research, Cathay General Hospital, Taipei City, Taiwan; 2. Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 3. Division of Interventional Cardiology, Department of Cardiovascular Center, Cathay General Hospital, Taipei City, Taiwan; 4. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; 5. Division of Cardiac Electrophysiology, Department of Cardiovascular Center, Cathay General Hospital, Taipei City, Taiwan; 6. Division of General Cardiology, Department of Cardiovascular Center, Cathay General Hospital, Taipei City, Taiwan; 7. Department of Internal Medicine, Cathay General Hospital, Taipei City, Taiwan; 8. School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan展开收起
17
天
Between Complexity and Translation: A Reflection on Cardiac EV Signaling, Subtype Function, and the Path to Clinical Validation
作者
Wenbin Lian; Yuangang Qiu展开收起
作者单位
1. The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China; 2. The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China; 3. Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China展开收起
22
天
Precision Secondary Prevention after Myocardial Infarction: Who Still Benefits from β-Blockade?
作者
Qiaoqiao Zheng; Yiqun Lou展开收起
作者单位
1. Department of Cardiovascular Medicine, XianJu People’s Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People’s Hospital, Affiliated Xianju’s Hospital, Hangzhou Medical College, Xianju Zhejiang, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天